Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep-Oct;53(5):394-402.
doi: 10.4103/ijp.IJP_654_20.

Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link

Affiliations
Review

Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link

Shruti Singh et al. Indian J Pharmacol. 2021 Sep-Oct.

Abstract

The severe acute respiratory syndrome coronavirus 2 is spreading like wildfire with no specific recommended treatment in sight. While some risk factors such as the presence of comorbidities, old age, and ethnicity have been recognized, not a lot is known about who the virus will strike first or impact more. In this hopeless scenario, exploration of time-tested facts about viral infections, in general, seems to be a sound basis to prop further research upon. The fact that immunity and its various determinants (e.g., micronutrients, sleep, and hygiene) have a crucial role to play in the defense against invading organisms, may be a good starting point for commencing research into these as yet undisclosed territories. Herein, the excellent immunomodulatory, antiviral, and anti-inflammatory roles of Vitamin D necessitate thorough investigation, particularly in COVID-19 perspective. This article reviews mechanisms and evidence suggesting the role Vitamin D plays in people infected by the newly identified COVID-19 virus. For this review, we searched the databases of Medline, PubMed, and Embase. We studied several meta-analyses and randomized controlled trials evaluating the role of Vitamin D in influenza and other contagious viral infections. We also reviewed the circumstantial and anecdotal evidence connecting Vitamin D with COVID-19 emerging recently. Consequently, it seems logical to conclude that the immune-enhancing, antiviral, anti-inflammatory, and lung-protective role of Vitamin D can be potentially lifesaving. Hence, Vitamin D deserves exhaustive exploration through rigorously designed and controlled scientific trials. Using Vitamin D as prophylaxis and/or chemotherapeutic treatment of COVID-19 infection is an approach worth considering. In this regard, mass assessment and subsequent supplementation can be tried, especially considering the mechanistic evidence in respiratory infections, low potential for toxicity, and widespread prevalence of the deficiency of Vitamin D affecting many people worldwide.

Keywords: COVID-19; Vitamin D; prophylaxis; treatment; viral respiratory illness.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Role of Vitamin D in COVID- 19. Severe acute respiratory syndrome coronavirus 2 and low levels of Vitamin D cause a downregulation of angiotensin-converting enzyme-2-dependent angiotensin (1–7) and enhancement of angiotensin-converting enzyme E-mediated angiotensin II levels. Lung injury is consequent to increased pulmonary vasoconstriction, inflammation, oxidative stress, and cytokine storm. These can well be attenuated by adequate levels of Vitamin D that restores a favorable angiotensin-converting enzyme/angiotensin-converting enzyme-2 ratio
Figure 2
Figure 2
Putative mechanisms by which Vitamin D helps in COVID-19

Comment in

  • Role of Vitamin D in COVID-19: Correspondence.
    Sookaromdee P, Wiwanitkit V. Sookaromdee P, et al. Indian J Pharmacol. 2022 Mar-Apr;54(2):153. doi: 10.4103/ijp.ijp_897_21. Indian J Pharmacol. 2022. PMID: 35546470 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Forni G, Mantovani A. COVID-19 Commission of Accademia Nazionale dei Lincei, Rome. COVID-19 vaccines: Where we stand and challenges ahead. Cell Death Differ. 2021;28:626–39. - PMC - PubMed
    1. Corti D, Purcell LA, Snell G, Veesler D. Tackling COVID-19 with neutralizing monoclonal antibodies. Cell. 2021;184:4593–5. - PMC - PubMed
    1. Benfield T, Bodilsen J, Brieghel C, Harboe ZB, Helleberg M, Holm C, et al. Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study. Clin Infect Dis. 2021 Jun 10;:ciab536. - PMC - PubMed
    1. 4de Masson A, Bouaziz JD, Sulimovic L, Cassius C, Jachiet M, Ionescu MA, et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France. J Am Acad Dermatol. 2020;83:667–70. - PMC - PubMed
    1. Beigel JH, Tomashek KM, Dodd LE. Remdesivir for the treatment of covid-19 – Preliminary report. Reply. N Engl J Med. 2020;383:994. - PubMed

MeSH terms